{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:55:21Z","timestamp":1791618921374,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08142-6","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:16:11Z","timestamp":1778901371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential biomarkers differentiating major depression from bipolar disorder depressive episodes by Olink Proteomics"],"prefix":"10.1186","volume":"26","author":[{"given":"Tingting","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"8142_CR1","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1176\/ajp.2006.163.9.1561","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163:1561\u20138.","journal-title":"Am J Psychiatry"},{"issue":"10027","key":"8142_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"I Grande","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561\u201372.","journal-title":"Lancet"},{"issue":"9820","key":"8142_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","volume":"379","author":"DJ Kupfer","year":"2012","unstructured":"Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379:(9820):1045\u201355.","journal-title":"Lancet"},{"issue":"1\u20132","key":"8142_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jad.2012.06.014","volume":"144","author":"D Dudek","year":"2013","unstructured":"Dudek D, Siwek M, Zieli\u0144ska D, et al. Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review. J Affect Disord. 2013;144(1\u20132):112\u20135.","journal-title":"J Affect Disord"},{"issue":"5","key":"8142_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/acps.12204","volume":"129","author":"RJ Baldessarini","year":"2014","unstructured":"Baldessarini RJ, Tondo L, Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand. 2014;129(5):383\u201392.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"8142_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/bdi.12499","volume":"19","author":"K Fritz","year":"2017","unstructured":"Fritz K, Russell AMT, Allwang C, et al. Is a delay in the diagnosis of bipolar disorder inevitable? Bipolar Disord. 2017;19(5):396\u2013400.","journal-title":"Bipolar Disord"},{"issue":"4","key":"8142_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1034\/j.1399-5618.2003.00037.x","volume":"5","author":"PL Morselli","year":"2003","unstructured":"Morselli PL, Elgie R. GAMIAN-Europe\/BEAM survey I - global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord. 2003;5(4):265\u201378.","journal-title":"Bipolar Disord"},{"issue":"2","key":"8142_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","volume":"72","author":"MM Sidor","year":"2011","unstructured":"Sidor MM, Macqueen GM. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J Clin Psychiatry. 2011;72(2):156\u201367.","journal-title":"J Clin Psychiatry"},{"key":"8142_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0165-0327(95)00049-6","volume":"36","author":"M Maes","year":"1995","unstructured":"Maes M, Vandoolaeghe E, Ranjan R, et al. Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord. 1995;36:29\u201336.","journal-title":"J Affect Disord"},{"key":"8142_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"M Maes","year":"2009","unstructured":"Maes M, Yirmyia R, Noraberg J, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24:27\u201353.","journal-title":"Metab Brain Dis"},{"key":"8142_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","volume":"25","author":"J Blume","year":"2011","unstructured":"Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25:221\u20139.","journal-title":"Brain Behav Immun"},{"key":"8142_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrn.2016.69","volume":"17","author":"ES Wohleb","year":"2016","unstructured":"Wohleb ES, Franklin T, Iwata M, et al. Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci. 2016;17:497\u2013511.","journal-title":"Nat Rev Neurosci"},{"key":"8142_CR13","doi-asserted-by":"publisher","first-page":"110391","DOI":"10.1016\/j.pnpbp.2021.110391","volume":"111","author":"MS Simon","year":"2021","unstructured":"Simon MS, Schiweck C, Arteaga-Henr\u00edquez G, et al. Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110391.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"8142_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012;139(3):230\u20139.","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"8142_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","volume":"104","author":"YK Kim","year":"2007","unstructured":"Kim YK, Jung HG, Myint AM, et al. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104(1\u20133):91\u20135.","journal-title":"J Affect Disord"},{"key":"8142_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/bdi.12259","volume":"17","author":"YM Bai","year":"2015","unstructured":"Bai YM, Su TP, Li CT, et al. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord. 2015;17:269\u201377.","journal-title":"Bipolar Disord"},{"key":"8142_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jad.2019.10.037","volume":"262","author":"AR Brunoni","year":"2020","unstructured":"Brunoni AR, Supasitthumrong T, Teixeira AL, et al. Differences in the immune-inflammatory profiles of unipolar and bipolar depression. J Affect Disord. 2020;262:8\u201315.","journal-title":"J Affect Disord"},{"issue":"2","key":"8142_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0269881109106931","volume":"25","author":"R Taurines","year":"2011","unstructured":"Taurines R, Dudley E, Grassl J, et al. Proteomic research in psychiatry. J Psychopharmacol. 2011;25(2):151\u201396.","journal-title":"J Psychopharmacol"},{"issue":"5\u20136","key":"8142_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/prca.201100061","volume":"6","author":"M Alsaif","year":"2012","unstructured":"Alsaif M, Guest PC, Schwarz E, et al. Analysis of serum and plasma identifies differences in molecular coverage, measurement variability, and candidate biomarker selection. Proteom Clin Appl. 2012;6(5\u20136):297\u2013303.","journal-title":"Proteom Clin Appl"},{"issue":"12","key":"8142_CR20","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1038\/tp.2015.185","volume":"5","author":"MA Frye","year":"2015","unstructured":"Frye MA, Nassan M, Jenkins GD, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiatry. 2015;5(12):e689.","journal-title":"Transl Psychiatry"},{"key":"8142_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","volume":"156","author":"F Haenisch","year":"2014","unstructured":"Haenisch F, Alsaif M, Guest PC, et al. Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3\u03b2 signaling in bipolar patients. J Affect Disord. 2014;156:139\u201343.","journal-title":"J Affect Disord"},{"key":"8142_CR22","doi-asserted-by":"publisher","first-page":"111816","DOI":"10.1016\/j.intimp.2024.111816","volume":"131","author":"F Xu","year":"2024","unstructured":"Xu F, Su Y, Wang X, et al. Olink proteomics analysis uncovers inflammatory proteins in patients with different states of bipolar disorder. Int Immunopharmacol. 2024;131:111816.","journal-title":"Int Immunopharmacol"},{"key":"8142_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.179.2.751","volume":"179","author":"CA Dahinden","year":"1994","unstructured":"Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med. 1994;179:751\u20136.","journal-title":"J Exp Med"},{"key":"8142_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1182\/blood.V90.3.909","volume":"90","author":"BJ Rollins","year":"1997","unstructured":"Rollins BJ. Chemokines Blood. 1997;90:909\u201328.","journal-title":"Chemokines Blood"},{"key":"8142_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JAA.S345759","volume":"15","author":"L Sun","year":"2022","unstructured":"Sun L, Peng B, Zhou J, et al. Difference of serum cytokine profile in allergic asthma patients according to disease severity. J Asthma Allergy. 2022;15:315\u201326.","journal-title":"J Asthma Allergy"},{"key":"8142_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","volume":"146","author":"Y Yang","year":"2020","unstructured":"Yang Y, Shen C, Li J, et al. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020;146:119\u2013e1274.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8142_CR27","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0092-8674(89)90591-6","volume":"56","author":"R Brachmann","year":"1989","unstructured":"Brachmann R, Lindquist PB, Nagashima M, et al. Transmembrane TGF-alpha precursors activate EGF\/TGF-alpha receptors. Cell. 1989;56(4):691\u2013700.","journal-title":"Cell"},{"issue":"20","key":"8142_CR28","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1073\/pnas.1534804100","volume":"100","author":"MX Shao","year":"2003","unstructured":"Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci U S A. 2003;100(20):11618\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"8142_CR29","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1093\/eurheartj\/ehad386","volume":"44","author":"J Golledge","year":"2023","unstructured":"Golledge J, Thanigaimani S, Powell JT, et al. Pathogenesis and management of abdominal aortic aneurysm. Eur Heart J. 2023;44(29):2682\u201397.","journal-title":"Eur Heart J"},{"issue":"1","key":"8142_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","volume":"110","author":"M Wolfl","year":"2007","unstructured":"Wolfl M, Kuball J, Ho WY, et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8\u2009+\u2009T cells responding to antigen without requiring knowledge of epitope specificities. Blood. 2007;110(1):201\u201310.","journal-title":"Blood"},{"key":"8142_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, et al. Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206\u201315.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"8142_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171\u201386.","journal-title":"Psychosom Med"},{"issue":"2","key":"8142_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","volume":"64","author":"C Gu","year":"2013","unstructured":"Gu C, Wu L, Li X. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013;64(2):477\u201385.","journal-title":"Cytokine"},{"issue":"3","key":"8142_CR34","first-page":"135","volume":"3","author":"X Fang","year":"2018","unstructured":"Fang X, Zhang Y, Fan W, et al. Interleukin-17 alteration in first-episode psychosis: a meta-analysis. Mol Neuropsychiatry. 2018;3(3):135\u201340.","journal-title":"Mol Neuropsychiatry"},{"issue":"2","key":"8142_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.semarthrit.2019.02.002","volume":"49","author":"PM Maloley","year":"2019","unstructured":"Maloley PM, England BR, Sayles H, et al. Post-traumatic stress disorder and serum cytokine and chemokine concentrations in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2019;49(2):229\u201335.","journal-title":"Semin Arthritis Rheum"},{"key":"8142_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","volume":"97","author":"A Nadeem","year":"2017","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, et al. IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression. Cytokine. 2017;97:14\u201324.","journal-title":"Cytokine"},{"key":"8142_CR37","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"AJ Lee","year":"2018","unstructured":"Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol. 2018;9:2061.","journal-title":"Front Immunol"},{"key":"8142_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","volume":"8","author":"D Jorgovanovic","year":"2020","unstructured":"Jorgovanovic D, Song M, Wang L, et al. Roles of IFN-\u03b3 in tumor progression and regression: a review. Biomark Res. 2020;8:49.","journal-title":"Biomark Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08142-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08142-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:40:28Z","timestamp":1787704828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08142-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8142"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08142-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before data collection, this study was approved by the institutional review boards of First Hospital of Hebei Medical University (20190404) in compliance with the Helsinki and an exemption from the informed consent was obtained. All data were anonymized before the analysis to safeguard patient privacy.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ChiCTR2200059426","order":4,"name":"Ethics","label":"Chinese Clinical Trial Registry","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"667"}}